GHA
RCPI

GW Henssler & Associates’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

GW Henssler & Associates’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-500
Closed -$1K – 193
2015
Q1 		$1K Hold
500
– – ﹤0.01% 168
2014
Q4 		$2K Hold
500
– – ﹤0.01% 163
2014
Q3 		$4K Hold
500
– – ﹤0.01% 141
2014
Q2 		$7K Buy
+500
New +$8.68K ﹤0.01% 141

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GW Henssler & Associates's RCPI Position: Q2 2015 in Review

GW Henssler & Associates sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2015, closing a stake of 500 shares — an estimated $1K sold.

GW Henssler & Associates first reported a position in RCPI in Q2 2014 and held it in 4 quarters. The position peaked at $7K in Q2 2014. 36 funds tracked by Wall St. Rank hold RCPI as of Q2 2015.

  • GW Henssler & Associates reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • GW Henssler & Associates sold 500 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1K.
  • GW Henssler & Associates first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • GW Henssler & Associates's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $7K in Q2 2014.
  • 36 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on GW Henssler & Associates's 13F filing for Q2 2015, filed 21 Jul 2015.